APA aipamena

Blagden, S. P., Cook, A. D., Poole, C., Howells, L., McNeish, I. A., Dean, A., . . . Clamp, A. R. (2020). Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): Quality-of-life results of a phase 3, randomised, controlled trial. Lancet Oncol.

Chicago Style aipamena

Blagden, Sarah P., et al. "Weekly Platinum-based Chemotherapy Versus 3-weekly Platinum-based Chemotherapy for Newly Diagnosed Ovarian Cancer (ICON8): Quality-of-life Results of a Phase 3, Randomised, Controlled Trial." Lancet Oncol 2020.

MLA aipamena

Blagden, Sarah P., et al. "Weekly Platinum-based Chemotherapy Versus 3-weekly Platinum-based Chemotherapy for Newly Diagnosed Ovarian Cancer (ICON8): Quality-of-life Results of a Phase 3, Randomised, Controlled Trial." Lancet Oncol 2020.